AlphaStocks

VAL vs VTRS

As of Sep 20, 2026, Valaris (VAL) scores 4.6/10 and Viatris (VTRS) 5.0/10 on AlphaStocks' five-model composite, so VTRS scores higher. VTRS trades 15% below its model fair value.

VAL

Valaris Ltd

4.6

Weak

$83.77

VTRS

Viatris Inc

5.0

Consider Buy

$16.93

VAL vs VTRS: Which is the Better Investment?

Valaris Ltd (VAL) scores 4.6/10 while Viatris Inc (VTRS) scores 5.0/10 on AlphaStocks' composite model. Viatris Inc has the higher composite rating of Consider Buy.

This comparison is algorithmically generated and is not financial advice.

MetricVALVTRS
Scores & Fundamentals
Composite Score4.6/105.0/10
RatingWeakConsider Buy
Price$83.77$16.93
P/E Ratio6.0
ROE35.0%114.4%
Market Cap$6B$20B
Fair Value$20.00
Dividend Yield
Sector Rank#37 of 80#115 of 168
Model Verdicts
PiotroskiStrongNeutral
BuffettAttractiveCaution
GrahamNeutralLimited Data
LynchNeutralAttractive
GreenblattAttractiveLimited Data
View full VALanalysis →View full VTRSanalysis →

Related comparisons

Compare any two stocks →

VAL vs VTRS: Which Stock Scores Higher?

Valaris Ltd (VAL) is in the Energy sector; Viatris Inc (VTRS) is in Health Care. VTRS currently leads with a composite score of 5.0/10 (Consider Buy) compared to VAL's 4.6/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer